Brief: Yichang Hec Changjiang Pharma Says Alogliptin Benzoate Tablets Of Dongguan Yangzhikang Pharma Obtained NMPA Approval
23/12/2020 09:52
Dec 23 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* ALOGLIPTIN BENZOATE TABLETS OF DONGGUAN YANGZHIKANG
PHARMACEUTICAL OBTAINED APPROVAL FOR LAUNCH FROM CHINA NMPA
Source text for Eikon: ID:nHKS6KJ04b
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million